These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10937356)

  • 21. Pioglitazone stimulates apolipoprotein A-I production without affecting HDL removal in HepG2 cells: involvement of PPAR-alpha.
    Qin S; Liu T; Kamanna VS; Kashyap ML
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2428-34. PubMed ID: 17872455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ApoA-II maintains HDL levels in part by inhibition of hepatic lipase. Studies In apoA-II and hepatic lipase double knockout mice.
    Weng W; Brandenburg NA; Zhong S; Halkias J; Wu L; Jiang XC; Tall A; Breslow JL
    J Lipid Res; 1999 Jun; 40(6):1064-70. PubMed ID: 10357838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice induces hyperlipidemia but reduces atherogenesis.
    Vergnes L; Baroukh N; Ostos MA; Castro G; Duverger N; Nanjee MN; Najib J; Fruchart JC; Miller NE; Zakin MM; Ochoa A
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2267-74. PubMed ID: 11031214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure and function of the apoA-IV T347S and Q360H common variants.
    Gomaraschi M; Putt WE; Pozzi S; Iametti S; Barbiroli A; Bonomi F; Favari E; Bernini F; Franceschini G; Talmud PJ; Calabresi L
    Biochem Biophys Res Commun; 2010 Feb; 393(1):126-30. PubMed ID: 20117098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice.
    Schultz JR; Gong EL; McCall MR; Nichols AV; Clift SM; Rubin EM
    J Biol Chem; 1992 Oct; 267(30):21630-6. PubMed ID: 1400473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of genetic deletion of platform apolipoproteins on the size distribution of the murine lipoproteome.
    Gordon SM; Li H; Zhu X; Tso P; Reardon CA; Shah AS; Lu LJ; Davidson WS
    J Proteomics; 2016 Sep; 146():184-94. PubMed ID: 27385375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Apolipoproteins A].
    Hamaguchi H
    Nihon Rinsho; 1994 Dec; 52(12):3108-12. PubMed ID: 7853697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human ApoA-IV overexpression in transgenic mice induces cAMP-stimulated cholesterol efflux from J774 macrophages to whole serum.
    Fournier N; Atger V; Paul JL; Sturm M; Duverger N; Rothblat GH; Moatti N
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1283-92. PubMed ID: 10807744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein.
    Blanco-Vaca F; Escolà-Gil JC; Martín-Campos JM; Julve J
    J Lipid Res; 2001 Nov; 42(11):1727-39. PubMed ID: 11714842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice.
    Voyiaziakis E; Goldberg IJ; Plump AS; Rubin EM; Breslow JL; Huang LS
    J Lipid Res; 1998 Feb; 39(2):313-21. PubMed ID: 9507992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection against atherogenesis in mice mediated by human apolipoprotein A-IV.
    Duverger N; Tremp G; Caillaud JM; Emmanuel F; Castro G; Fruchart JC; Steinmetz A; Denèfle P
    Science; 1996 Aug; 273(5277):966-8. PubMed ID: 8688083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein A-II: a protein in search of a function.
    Hedrick CC; Lusis AJ
    Can J Cardiol; 1994 May; 10(4):453-9. PubMed ID: 8193990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV.
    Cohen RD; Castellani LW; Qiao JH; Van Lenten BJ; Lusis AJ; Reue K
    J Clin Invest; 1997 Apr; 99(8):1906-16. PubMed ID: 9109435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arg123-Tyr166 domain of human ApoA-I is critical for HDL-mediated inhibition of macrophage homing and early atherosclerosis in mice.
    Holvoet P; Peeters K; Lund-Katz S; Mertens A; Verhamme P; Quarck R; Stengel D; Lox M; Deridder E; Bernar H; Nickel M; Theilmeier G; Ninio E; Phillips MC
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):1977-83. PubMed ID: 11742873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice.
    Hedrick CC; Castellani LW; Warden CH; Puppione DL; Lusis AJ
    J Biol Chem; 1993 Sep; 268(27):20676-82. PubMed ID: 8376417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estradiol stimulates apolipoprotein A-I- but not A-II-containing particle synthesis and secretion by stimulating mRNA transcription rate in Hep G2 cells.
    Jin FY; Kamanna VS; Kashyap ML
    Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):999-1006. PubMed ID: 9633943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clearance of cationized LDL cholesterol from a muscle depot is not enhanced in human apolipoprotein A-IV transgenic mice.
    Stein Y; Stein O; Duverger N; Halperin G; Dabach Y; Hollander G; Ben-Naim M
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):179-84. PubMed ID: 10634815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3.
    Walsh A; Ito Y; Breslow JL
    J Biol Chem; 1989 Apr; 264(11):6488-94. PubMed ID: 2495286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins.
    Rosales C; Gillard BK; Courtney HS; Blanco-Vaca F; Pownall HJ
    Biochemistry; 2009 Aug; 48(33):8070-6. PubMed ID: 19618959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein A-I and the molecular variant apoA-I(Milano): evaluation of the antiatherogenic effects in knock-in mouse model.
    Parolini C; Chiesa G; Gong E; Caligari S; Cortese MM; Koga T; Forte TM; Rubin EM
    Atherosclerosis; 2005 Dec; 183(2):222-9. PubMed ID: 16285990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.